help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frystyk, J.
Right arrow Articles by Baxter, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frystyk, J.
Right arrow Articles by Baxter, R. C.
Endocrinology Vol. 139, No. 3 1454-1457
Copyright © 1998 by The Endocrine Society


ARTICLES

Competitive Binding Assay for Determination of Rat Insulin-Like Growth Factor Binding Protein-3

Jan Frystyk and Robert C. Baxter

Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, Sydney, NSW 2065, Australia

Address all correspondence and requests for reprints to: Dr. Jan Frystyk, Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales 2065, Australia.


    Abstract
 Top
 Abstract
 
We describe a novel competitive assay for rat insulin-like growth factor (IGF)-binding protein-3 (rIGFBP-3) based on the ability of IGFBP-3 to form a ternary complex with the acid labile subunit (ALS) in the presence of IGF. Human (h)ALS was bound to test tubes pre-coated with anti-human ALS antibody. The assay depends on competition between a covalent complex of 125I-hIGF-I and hIGFBP-3, added as tracer, and hIGFBP-3 or rIGFBP-3 in standards and test samples, for binding to the immobilized hALS. Purified natural hIGFBP-3 served as standard. Human IGFBP-3 and rIGFBP-3 were able to compete for tracer binding in the presence, but not in the absence, of IGF-I. Before assay, rat serum samples were acidified to denature endogenous ALS. Standards ranged from 0.10 (lower detection limit) to 20 ng/tube. Rat serum, semipurified rIGFBP-3, human serum and purified hIGFBP-3 diluted in parallel. The level of rIGFBP-3 was 1.63 ± 0.28 mg/l (mean ± SEM) in young rats and increased to 3.41 ± 0.26 mg/l (p < 0.05) in old rats (n = 5–6). Fasting for 3 days reduced rIGFBP-3 from 2.41 ± 0.27 to 1.33 ± 0.14 mg/l (p < 0.05). Levels of rIGFBP-3 were reduced in hypophysectomized (0.16 ± 0.04 mg/l; p < 0.05) and diabetic rats (1.04 ± 0.30 mg/l; p < 0.05), and normal in insulin-treated diabetic rats (2.49 ± 0.04 mg/l; ns), when compared to controls (2.79 ± 0.22 mg/l). Changes in levels of IGFBP-3 paralleled those of immunoreactive rALS. We conclude that this assay provides a novel method of quantitating functional IGFBP-3 in rat serum.

Received October 6, 1997.




This article has been cited by other articles:


Home page
EndocrinologyHome page
S.-E. Kong, R. C. Baxter, and P. J. D. Delhanty
Age-Dependent Regulation of the Acid-Labile Subunit in Response to Fasting-Refeeding in Rats
Endocrinology, December 1, 2002; 143(12): 4505 - 4512.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. J. D. Delhanty, C. D. Scott, S. Babu, and R. C. Baxter
Acid-labile subunit regulation during the early stages of liver regeneration: implications for glucoregulation
Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E287 - E295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Frystyk, P. J. D. Delhanty, C. Skjarbak, and R. C. Baxter
Changes in the circulating IGF system during short-term fasting and refeeding in rats
Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E245 - E252.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Frystyk, H. Gronbak, C. Skjarbak, A. Flyvbjerg, H. Orskov, and R. C. Baxter
Developmental Changes in Serum Levels of Free and Total Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 and -3, and the Acid-Labile Subunit in Rats
Endocrinology, October 1, 1998; 139(10): 4286 - 4292.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frystyk, J.
Right arrow Articles by Baxter, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frystyk, J.
Right arrow Articles by Baxter, R. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals